CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $46.06M, above the global median of $16.24M
- FinancialsAltman Z-Score 2.96: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
947.94MCAD688.90M · vs all stocks (USD)
Trailing P/E
64.40xRevenue (TTM)
547.31MCAD397.75M · vs all stocks (USD)
Profit Margin
2.72%Beta
0.0460xvs all stocks
52-Week Change
49.61%vs all stocks
Market Capitalization
947.94MCAD688.90M · vs all stocks (USD)
Enterprise Value
877.74MCAD637.89M · vs all stocks (USD)
Trailing P/E
64.40xForward P/E
37.15xPEG Ratio
-0.2576xPrice to Sales (TTM)
1.73xPrice to Book (MRQ)
1.19xEnterprise to Revenue
1.60xEnterprise to EBITDA
10.81xGross Margin
48.27%Profit Margin
2.72%Operating Margin
6.21%Return on Assets (TTM)
1.32%Return on Equity (TTM)
1.91%Revenue (TTM)
547.31MCAD397.75M · vs all stocks (USD)
Revenue per Share (TTM)
5.53CADUpdated Aug 21, 2026Quarterly Revenue Growth
34.30%Gross Profit (TTM)
259.26MCAD188.41M · vs all stocks (USD)
EBITDA (TTM)
87.42MCAD63.53M · vs all stocks (USD)
Net Income (TTM)
14.87MCAD10.81M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
63.74%Operating Cash Flow (TTM)
115.25MCAD83.76M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
63.38MCAD46.06M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.00CADUpdated Aug 21, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Revenue
450.09MCADFY2025 · Dec 31, 2025Cost of Goods Sold
249.86MCADFY2025 · Dec 31, 2025Gross Profit
200.23MCADFY2025 · Dec 31, 2025Operating Income
-2.35MCAD-1.71M · vs all stocks (USD)
Pre-tax Income
-6.70MCADFY2025 · Dec 31, 2025Income Tax Expense
-1.33MCADFY2025 · Dec 31, 2025Net Income
-5.37MCADFY2025 · Dec 31, 2025EBIT
3.72MCADFY2025 · Dec 31, 2025EBITDA (Income Statement)
58.15MCADFY2025 · Dec 31, 2025Research & Development
28.98MCADFY2025 · Dec 31, 2025Selling, General & Administrative
124.11MCADFY2025 · Dec 31, 2025Non-operating Interest Income
6.21MCADFY2025 · Dec 31, 2025Non-operating Interest Expense
10.42MCADFY2025 · Dec 31, 2025EPS (Basic)
-0.0500CADFY2025 · Dec 31, 2025EPS (Diluted)
-0.0500CADFY2025 · Dec 31, 2025Basic Shares Outstanding
99.57MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
99.57MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-5.37MCADFY2025 · Dec 31, 2025Operating Cash Flow
63.63MCADFY2025 · Dec 31, 2025Free Cash Flow
61.76MCADDerived from operating cash flow minus capital expenditure. This filing charges 56.57M of depreciation against 1.88M of capital expenditure, and its own free-cash-flow line reads 35.26M.FY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
76.45MCADFY2025 · Dec 31, 2025Income Tax Paid
2.89MCADFY2025 · Dec 31, 2025Interest Paid
7.60MCADFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-5.37MCADFY2025 · Dec 31, 2025Depreciation & Amortization
56.57MCADFY2025 · Dec 31, 2025Deferred Taxes (CF)
-3.81MCADFY2025 · Dec 31, 2025Stock-based Compensation
8.11MCADFY2025 · Dec 31, 2025Other Non-cash Items
7.86MCADFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-26.53MCADFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
42.10MCADFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-15.30MCADFY2025 · Dec 31, 2025Capital Expenditures
-1.88MCADFY2025 · Dec 31, 2025Net Intangibles (CF)
-31.79MCADFY2025 · Dec 31, 2025Net Acquisitions
-110.08MCADFY2025 · Dec 31, 2025Purchase of Investments
-70.39MCADFY2025 · Dec 31, 2025Sale of Investments
121.38MCADFY2025 · Dec 31, 2025Other Investing Activity
17.60MCADFY2025 · Dec 31, 2025Net Investing Cash Flow
-43.37MCADFY2025 · Dec 31, 2025Long-term Debt Issuance
112.07MCADFY2025 · Dec 31, 2025Long-term Debt Payments
-91.55MCADFY2025 · Dec 31, 2025Common Stock Repurchase
-6.35MCADFY2025 · Dec 31, 2025Common Dividends Paid
0.00CADFY2025 · Dec 31, 2025Other Financing Charges
-1.67MCADFY2025 · Dec 31, 2025Net Financing Cash Flow
12.50MCADFY2025 · Dec 31, 2025Shares Outstanding
98.22MSharesUpdated Aug 21, 2026Float Shares
60.29MSharesUpdated Aug 21, 2026Shares Short
1.43MSharesUpdated Aug 21, 2026Short Ratio
11.41daysvs all stocks
% Held by Insiders
46.99%vs all stocks
% Held by Institutions
18.12%vs all stocks
Total Cash (MRQ)
121.17MCAD88.06M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.23CADUpdated Aug 21, 2026Total Debt (MRQ)
34.28MCAD24.91M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0429xCurrent Ratio (MRQ)
2.28xBook Value per Share (MRQ)
8.13CADUpdated Aug 21, 2026Total Assets
1.05BCAD760.39M · vs all stocks (USD)
Total Current Assets
394.83MCADFY2025 · Dec 31, 2025Total Liabilities
279.03MCADFY2025 · Dec 31, 2025Total Non-current Assets
651.47MCADFY2025 · Dec 31, 2025Total Non-current Liabilities
113.77MCADFY2025 · Dec 31, 2025Total Current Liabilities
165.26MCADFY2025 · Dec 31, 2025Cash
71.09MCADFY2025 · Dec 31, 2025Cash Equivalents
5.35MCADFY2025 · Dec 31, 2025Cash & Cash Equivalents
76.45MCADFY2025 · Dec 31, 2025Other Short-term Investments
18.95MCADFY2025 · Dec 31, 2025Accounts Receivable
127.78MCADFY2025 · Dec 31, 2025Inventory
135.87MCADFY2025 · Dec 31, 2025Accounts Payable
120.87MCADFY2025 · Dec 31, 2025Short-term Debt
20.13MCADFY2025 · Dec 31, 2025Other Current Liabilities
12.88MCADFY2025 · Dec 31, 2025Long-term Debt
57.78MCADFY2025 · Dec 31, 2025Common Stock (Book)
530.14MCADFY2025 · Dec 31, 2025Retained Earnings
148.94MCADFY2025 · Dec 31, 2025Total Shareholders' Equity
767.27MCAD557.61M · vs all stocks (USD)
52-Week Low
5.66CADUpdated Aug 21, 202652-Week High
10.17CADUpdated Aug 21, 202652-Week Change
49.61%vs all stocks
Beta
0.0460xvs all stocks
50-Day MA
9.61CADUpdated Aug 21, 2026200-Day MA
7.43CADUpdated Aug 21, 2026Avg 10-Day Volume
91.78KSharesUpdated Aug 21, 2026Avg 30-Day Volume
99.10KSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.1500CADUpdated Aug 21, 2026Other Income / Expense
-136.00KCADFY2025 · Dec 31, 20251 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Three-Year Positive Free Cash Flow With Elevated ADX Asymmetry And 50w SMA Above 200w SMA
Three years of positive free cash flow, with the 50-week average above the 200-week.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.48Profit Margin: 0.03
Financial Health
Altman Z-Score 2.96: safe zoneNotable
Altman Z-Score: 2.96
High earnings qualityNotable
Earnings Quality Score: 1.85
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $46.06M, above the global median of $16.24MNotable
Levered free cash flow (USD): 46,060,691.084Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Beijing Science Sun Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Nanjing Vishee Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shandong Keyuan Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
BridgeBio Oncology Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hangzhou Minsheng Healthcare Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Ars Pharmaceuticals Inc
Tier 1ProductionApproval-Gated PipelineRule
Hunan Fangsheng Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Revenio Group Oyj
Tier 1ProductionApproval-Gated PipelineRule
Xiangxue Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai ShenQi Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Moon Environment Technology Co., Ltd.
1 interpretationThree-Year Positive Free Cash Flow With Elevated ADX Asymmetry And 50w SMA Above 200w SMA
Springfield Properties Plc
1 interpretationThree-Year Positive Free Cash Flow With Elevated ADX Asymmetry And 50w SMA Above 200w SMA
Novartis AG
1 interpretationThree-Year Positive Free Cash Flow With Elevated ADX Asymmetry And 50w SMA Above 200w SMA